Latest News

Stay up to date with the latest stock market news from around the world. From breaking news written by our finance analysts to event-driven market news on a global scale.

NYSE:NIO
NYSE:NIOAuto

Is NIO (NIO) Fairly Priced After Recent Share Price Recovery?

If you are wondering whether NIO at about US$4.89 is a bargain or a value trap, you are not alone. This breakdown is here to unpack that question in more detail. The share price has moved 8.2% over the last week and 5.4% over the last 30 days, while the year to date return is a 4.9% decline and the 1 year return sits at 12.9%. This compares with much weaker 3 year and 5 year returns of 52.6% and 91.8% declines respectively. Recent coverage of NIO has focused on its position in the electric...
NYSE:KLAR
NYSE:KLARDiversified Financial

Assessing Klarna Group (KLAR) Valuation After Recent Share Price Weakness And Conflicting Fair Value Signals

Why Klarna Group is on investors’ radar Klarna Group (KLAR) has drawn attention after recent trading, with the share price at US$20.37 and short term returns under pressure over the past week, month, and past 3 months. See our latest analysis for Klarna Group. For context, Klarna Group’s recent weakness has been building for a while, with a 1-day share price return of 0.73% decline, a 30-day share price return of 35.23% decline, and a year to date share price return of 28.70% decline. This...
TSE:4568
TSE:4568Pharmaceuticals

A Look At Daiichi Sankyo (TSE:4568) Valuation After DATROWAY Priority Review Milestone

Daiichi Sankyo Company (TSE:4568) shares are in focus after the U.S. FDA accepted and granted Priority Review to a supplemental Biologics License Application for DATROWAY in advanced triple negative breast cancer. See our latest analysis for Daiichi Sankyo Company. At a share price of ¥2,952.0, Daiichi Sankyo’s 1 day share price return of 2.89% and 7 day gain of 1.22% contrast with a 30 day share price decline of 16.66% and a 1 year total shareholder return of 19.19% in the red. This suggests...